E-LIB Suche - Ergebnisse für: Pistilli, B

1

Investigating sexual health after breast cancer by longitud..:

Franzoi, M.A. ; Aupomerol, M. ; Havas, J....
ESMO Open. 9 (2024) 2 - p. 102236 , 2024

Link: https://doi.org/10.1016/..

2

Is controlled ovarian stimulation safe in patients with hor..:

Benvenuti, C. ; Laot, L. ; Grinda, T....
ESMO Open. 9 (2024) 2 - p. 102228 , 2024

Link: https://doi.org/10.1016/..

3

52P Comparing the genomic landscape of de novo vs recurrent..:

Giugliano, F. ; Douglas, J.R. Dixon ; Dien, A. Tran...
ESMO Open. 9 (2024) - p. 103059 , 2024

Link: https://doi.org/10.1016/..

4

7P Trastuzumab deruxtecan (T-DXd) for advanced breast cance..:

Dieras, V.C. ; André, F. ; Lusque, A....
ESMO Open. 9 (2024) - p. 103016 , 2024

Link: https://doi.org/10.1016/..

5

159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvan..:

Loibl, S. ; Tolaney, S.M. ; Schmid, P....
ESMO Open. 9 (2024) - p. 103146 , 2024

Link: https://doi.org/10.1016/..

6

522P Intra-arterial hepatic chemotherapy: Role beyond color..:

El Rawadi, E.J. ; Boileve, A. ; Dall'Olio, F.G....
Annals of Oncology. 35 (2024) - p. S208 , 2024

Link: https://doi.org/10.1016/..

7

113MO NATALEE update: Safety and treatment (tx) duration of..:

Barrios, C.H. ; Harbeck, N. ; Hortobagyi, G.N....
ESMO Open. 9 (2024) - p. 103101 , 2024

Link: https://doi.org/10.1016/..

8

Incidence and outcome of brain and/or leptomeningeal metast..:

Epaillard, N. ; Lusque, A. ; Jacot, W....
ESMO Open. 9 (2024) 5 - p. 103447 , 2024

Link: https://doi.org/10.1016/..

9

142P Exploring 18F-FDG PET as a predictior of immune-relate..:

Daverio, A.L. ; Giugliano, F. ; Douglas, J.R. Dixon...
ESMO Open. 9 (2024) - p. 103129 , 2024

Link: https://doi.org/10.1016/..

10

LBA2 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT)..:

Jhaveri, K. ; Bardia, A. ; Im, S-A....
ESMO Open. 9 (2024) - p. 103479 , 2024

Link: https://doi.org/10.1016/..

11

A bio-behavioral model of systemic inflammation at breast c..:

Di Meglio, A. ; Havas, J. ; Pagliuca, M....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

12

217P Switching cyclin-dependent kinase inhibitors (CDK4/6i)..:

Benvenuti, C. ; Viansone, A.A. ; Jacobs, F....
ESMO Open. 9 (2024) - p. 103239 , 2024

Link: https://doi.org/10.1016/..

13

132P Clinico-pathological characteristics, treatments and s..:

Giugliano, F. ; Bertaut, A. ; Blanc, J....
ESMO Open. 9 (2024) - p. 103119 , 2024

Link: https://doi.org/10.1016/..

14

29P Prevalence of high tumor mutational burden (TMB) in pat..:

Ribeiro, J.T.M.L.M. ; Dien, A. Tran ; Mignot, L....
ESMO Open. 8 (2023) 1 - p. 101253 , 2023

Link: https://doi.org/10.1016/..

15

227P Molecular landscape of patients with early relapsed me..:

Grinda, T. ; Dien, A. Tran ; Bayle, A....
ESMO Open. 8 (2023) 1 - p. 101416 , 2023

Link: https://doi.org/10.1016/..